2.3 Scientific Communication Platforms and Evidence-Based Language

Scientific Communication Platforms and Evidence-Based Language

A Scientific Communication Platform (SCP) is an organized reference used to keep scientific communication accurate, consistent, current, and traceable. It can connect disease context, unmet need, mechanism, clinical findings, safety, patient experience, and health outcomes to verified sources and important qualifications.

An SCP is not itself an official regulatory category, a substitute for source verification, or a script that every publication must repeat. Organizations use different names and architectures. The useful principle is controlled evidence with transparent provenance.

A defensible architecture

A platform can be organized into:

1. Scientific themes: broad areas such as disease burden, mechanism, clinical outcomes, safety, and patient experience.
2. Supported statements: concise propositions that accurately reflect the evidence.
3. Qualifications: population, comparator, endpoint, analysis set, time point, uncertainty, limitations, investigational or approval status, and geographic scope.
4. Source links: precise citations to a protocol, statistical analysis plan, clinical study report, verified analysis, health-authority document, or publication.
5. Use and status fields: allowed context, owner, review date, superseded version, and approval state under the organization's process.

A statement such as “treatment reduced risk by 40%” is incomplete without the outcome, population, comparator, time, effect estimate, confidence interval where applicable, and absolute context. The platform should make those elements easy to retrieve rather than reduce the evidence to a slogan.

Source hierarchy and verification

The most appropriate source depends on the statement. A final verified analysis may support an unpublished congress abstract; a peer-reviewed article may support a disease-background statement; the current approved labeling controls an approved indication or warning in a regulated context. A press release is rarely the best evidentiary source when verified data are available.

Record exact table, figure, page, dataset, or analysis references where feasible. Note data cutoff and version. If sources disagree, do not silently choose the favorable one. Reconcile the population, definition, analysis, date, and authority, and escalate unresolved differences.

“Peer reviewed” does not mean infallible, and a clinical study report does not automatically authorize public disclosure. Evaluate confidentiality, privacy, embargo, copyright, contract, product status, and intended audience separately.

Controlled language without invented bans

A scientific lexicon helps teams use terms consistently: disease classifications, endpoints, analysis populations, product names, abbreviations, adverse-event terminology, and statistical descriptions. It should identify terms that need context and examples of acceptable evidence-based wording.

Avoid unsupported superlatives such as “best,” “unmatched,” “game-changing,” or “miracle.” Avoid absolute claims such as “safe” or “no risk.” A claim of superiority should match the design, estimand, analysis, and evidence; a favorable numerical trend in a single-arm study does not establish comparative superiority.

Do not turn sensible caution into invented universal rules. Whether an INN, development code, or brand name is appropriate depends on product status, venue style, jurisdiction, and purpose. “Breakthrough Therapy” can be an accurate formal FDA designation in context, even though “breakthrough” used as promotional praise may mislead. “First in class” may describe a verifiable regulatory or mechanistic fact in some contexts but should not be used as unsupported value language.

Balance and quantitative context

A communication should present material benefits, harms, limitations, and uncertainty in proportion to its purpose and format. An abstract cannot reproduce every safety table, but it should not create a favorable impression by suppressing a material harm. A manuscript should follow the design-specific reporting guideline and target journal rather than a generic platform template.

Choose effect measures that help the audience interpret the evidence. Relative and absolute effects often complement each other, but not every estimate requires both forms. Confidence intervals are generally more informative than a threshold declaration alone. Exact p-values may be useful when reported under the analysis plan and venue style; they are not a universal substitute for effect size and precision.

Avoid cross-trial comparisons that ignore population, follow-up, endpoint, or design differences. If an indirect comparison or network meta-analysis supports a statement, identify the method and its assumptions.

Adapting across deliverables

The source evidence may be adapted for:

• a primary or secondary manuscript;
• an abstract, poster, or oral presentation;
• a review or educational article;
• a plain-language summary;
• a visual abstract, video, podcast, or social post;
• a medical-information response or other scientific communication.

Adaptation changes depth, vocabulary, and design—not the result. Preserve denominators, time points, comparator, direction, analysis status, and caveats. A plain-language version should explain uncertainty, not erase it. A social asset should not elevate an exploratory subgroup. Each deliverable follows its own venue, regulatory, ethical, and rights requirements.

Using one platform does not justify redundant publication. Each publication should have a legitimate scientific purpose, and related outputs should cross-reference prior dissemination where required.

Governance and version control

Assign an accountable scientific owner and a documented review process. Relevant reviewers may include clinical, statistical, safety, regulatory, legal or compliance, publication, medical-information, health-outcomes, and patient-engagement expertise. Commercial insight may identify audience questions, but commercial objectives must not determine scientific conclusions or suppress unfavorable evidence.

Use change control:

1. log the proposed statement and source;
2. verify the data and context;
3. record reviewer decisions and qualifications;
4. assign version, date, and owner;
5. distribute the approved version to users;
6. retire superseded language without erasing history;
7. reassess after new data, correction, label change, safety signal, or guideline update.

A platform that is not maintained can spread obsolete information more efficiently than no platform at all. Before reuse, confirm that the statement and source remain current and fit the proposed context.